Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000398495 | SCV000458955 | likely benign | Capillary malformation-arteriovenous malformation 1 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000304263 | SCV000458956 | likely benign | Parkes Weber syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000869395 | SCV001010818 | benign | Capillary malformation-arteriovenous malformation syndrome | 2025-01-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356485 | SCV002655650 | likely benign | Cardiovascular phenotype | 2017-06-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV004584694 | SCV005075515 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | RASA1: BP4, BP7, BS1, BS2 |